eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
5/2007
vol. 11
 
Share:
Share:
more
 
 
abstract:

The value of radiotherapy in the treatment of aged-related macular degeneration (AMD)

Małgorzata Zarzycka
,
Ewa Ziółkowska
,
Aleksandra Słonina

Współczesna Onkologia (2007) vol. 11; 5 (267-271)
Online publish date: 2007/07/16
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Age-related macular degeneration (AMD) is the leading cause of blindness in patiens older then 65 years. There are two forms of AMD: exudative ”wet” and nonexudative ”dry”. Most of the lesions are not amenable to laser therapy because of their vicinity to the fovea. Earlier studies suggested that radiotherapy may inhibit further loss of visual acuity but following studies rendered contradictory results. In recent years, treatment of beningn disease has again attracted the interest of the radiation oncology community in the Western part of the world. Radiotherapy has been given successfully to patiens suffering from a wide variety diseases and AMD is one of them. The present article extensively reviews the clinical studies to define the role of radiotherapy in the treatment of AMD.
keywords:

age-related macular degeneration (AMD), radiation therapy, visual acuity (VA)

Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe